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Study Objective. To identify sensitive and speciﬁc histological criteria for endometritis in women with laparoscopically-conﬁrmed
acute salpingitis. Methods. Women, age 18–40 years of age presenting with complaints of lower abdominal pain ≤2w e e k sa n d
no antibiotics use in past two weeks, were enrolled. They underwent clinical examination, screening for HIV; other sexually
transmitted infections plus endometrial biopsy sampling for histopathology. Diagnostic laparoscopy conﬁrmed the diagnosis of
acute salpingitis. Controls were women undergoing tubal ligation and HIV-1 infected women asymptomatic for genital tract
infection. Results. Of 125 women with laparoscopically-conﬁrmed salpingitis, 38% were HIV-1 seropositive. Nineteen HIV-1
negative controls were recruited. For the diagnosis of endometritis, ≥1 plasma cells (PC) and ≥3 polymorphonuclear lymphocytes
(PMN) per HPF in the endometrium had a sensitivity of 74% for HIV-1-seropositive, 63% for HIV-1-seronegative women with a
speciﬁcity of 75% and positive predictive value of 85% regardless of HIV-1-infection for predicting moderate to severe salpingitis.
For HIV-1-seronegative women with mild salpingitis, ≥1P Ca n d≥3 PMN had a sensitivity of 16% and a PPV of 57%. Conclusion.
Endometrial histology, did not perform well as a surrogate marker for moderate to severe salpingitis, and failed as a surrogate
marker for mild salpingitis.
1.Introduction
In Africa, pelvic inﬂammatory disease (PID) and its sequelae
are a predominant cause of gynecologic morbidity [1, 2].
These include tubal factor infertility, ectopic pregnancy,
chronic pelvic pain, and recurrent pelvic infections [3, 4].
HIV-1 seroprevalence in women with PID is consistently
2–7 times greater than measured in matched populations
without PID [5–7]; both infections are most commonly
acquired through unprotected sexual activity. Prompt diag-
nosis and treatment of women with upper genital tract
infections is important in reducing morbidity, but it is
complicated by lack of a sensitive and speciﬁc clinical and
laboratory diagnostic test. Laparoscopy is the gold standard
forthediagnosisofsalpingitis,butisnotpracticalforroutine
clinical practice.
Endometrial histopathology is often used as a surrogate
for upper genital tract infection. Kiviat et al. [8]e v a l u a t e d2 Infectious Diseases in Obstetrics and Gynecology
women with clinical PID; evidence of endometritis as
deﬁned by ≥1 plasma cell (PC) and ≥5 polymorphonuclear
lymphocytes (PMN) per high-powered ﬁeld (hpf) was 92%
sensitive and 87% speciﬁc compared with visual ﬁndings
of salpingitis determined by laparoscopy [8]. Using the
same diagnostic criteria in a study of acute salpingitis in
Kenya, plasma cell endometritis as deﬁned by ≥1PC/hpfwas
identiﬁed in 49% of women with salpingitis: this increased
with disease severity and HIV-infection [7]. Studies on HIV-
1-infected women have found an increased prevalence of
plasma cell endometritis [9] even in the absence of clinical
disease [10, 11].
Thus, we conducted this analysis to determine the opti-
mum endometrial histopathological criteria for predicting
salpingitis in a population with a high HIV-1 seroprevalence.
We anticipate that these data will help to plan future clinical
trials, increase the understanding of the pathogenesis of
upper genital tract infection among HIV-1 infected women,
and in certain circumstances provide a tool to conﬁrm the
clinical diagnosis of PID.
2.MaterialsandMethods
Study procedures have been previously detailed [12]. Brieﬂy,
betweenApril2000andJuly2002,womenaged18–40admit-
ted to Kenyatta National Hospital (KNH) acute gynecology
ward with a complaint of lower abdominal/pelvic pain for
2 weeks or less plus one or more of the following signs or
symptoms: temperature ≥ 38◦C, dysuria, and complaint of
abnormal vaginal discharge were eligible for enrollment.
After induction of anesthesia, an endometrial biopsy was
obtainedwithaPipellesuctioncurette(Unimar,Inc.,Wilton,
Conn). At laparoscopy, samples from peritoneal ﬂuid, tubal
ostia, and pyosalpinx/tubo-ovarian abscess (TOA) were
obtained for N. gonorrhoeae and C. trachomatis PCR. Using
the Jacobson and Westrom criteria [13], the severity of acute
salpingitis was graded as (1) mild (tubal erythema or edema,
mobile tubes, and with or without spontaneous exudate),
(2) moderate (marked tubal erythema and edema, limited
tubal mobility, questionable or no tubal patency, and gross
exudate), and (3) severe (pyosalpinx or TOA).
Weenrolledtwosetsofcontrols.Theﬁrstgroupincluded
HIV-1-seronegative women presenting to the KNH family
planning clinic. Women desiring permanent sterilization
underwent laparoscopic tubal ligation preceded by an
endometrial biopsy obtained using a Pipelle suction curette.
HIV-1-seropositive controls were enrolled from an HIV
care and treatment clinic at the Center for Respiratory
Disease Research at the Kenya Medical Research Institute.
Subjects had no clinical evidence of PID. Enrollment and
study procedures of the HIV-1-seropositive control group
are detailed elsewhere [14]. After informed consent was
obtained, an endometrial pipelle biopsy was obtained in the
research clinic.
2.1. Laboratory Methods. Samples from the cervix, endo-
metrium, fallopian tube, and abscess were examined by PCR
(Roche Molecular Diagnostics, Pleasanton, Calif, USA) for
N. gonorrhoeae and C. trachomatis. Endometrial specimens
were ﬁxed in 10% buﬀered formalin, processed, and stained
withhematoxylin,eosin,andmethylgreenpyronin.PMNsin
glandsandPCsinstromawerecountedperhigh-powerﬁeld.
One pathologist (NK) who was blinded to the patients’ diag-
nosis read the slides. Serum was tested for HIV antibodies by
ELISA (Detect HIV, BioChem ImmunoSystems, Montreal,
Canada) with positive results conﬁrmed by a second ELISA
(Recombigen, Cambridge Biotech, Ireland).
2.2. Data Analysis. Data were analyzed using SPSS for
Windows 10.0 (SPSS Inc., Chicago, USA). Univariate anal-
yses used chi-square and Fisher’s exact tests for categorical
data and Student’s t-test for continuous variables. Logistic
regression was done for multivariate analysis.
3. Results
3.1. Description of Study Population. One hundred and sixty
women were enrolled with clinical PID, 140 (88%) had
laparoscopically conﬁrmed salpingitis, 125 (89%) of whom
had an endometrial biopsy specimen: 56 (45%) had mild,
31 (25%) had moderate, and 38 (30%) had severe disease
based on laparoscopic criteria. Nineteen women had other
diagnoses at laparoscopy including appendicular abscess
(n = 2), endometriosis (n = 1), ovarian cyst (n =
12), frozen pelvis (n = 1), pelvic tuberculosis (n = 1),
cancer of the sigmoid volvulus with abscess (n = 1), and
ovarian torsion (n = 1). Asymptomatic women (n = 20)
desiring permanent sterilization underwent laparoscopic
tuballigationandservedasHIV-1-negativecontrols.Asingle
control subject had a sticky exudate emanating from the
Fallopiantubesandwasexcludedfromtheanalysisleaving19
HIV-1-seronegative controls. Forty-ﬁve asymptomatic HIV-
1-seropositive controls were enrolled from an HIV care
clinic; one woman had C. trachomatis detected.
Forty-eight (38%) of the women with salpingitis were
HIV-seropositive. Women with salpingitis were younger,
less likely to be married, and less likely to have ever used
contraception (Table 1). As expected, none of the HIV-1-
seronegative controls had signs or symptoms consistent with
PID, and none were infected with N. gonorrhoeae or C.
trachomatis.H o w e v e r ,T. vaginalis was detected in a similar
proportion of salpingitis cases (23%) and HIV-seronegative
controls (21%) (Table 1).
3.2. Factors Associated with Evaluable and Unevaluable
Endometrial Histopathology. Of the 125 women with salpin-
gitis, endometrial biopsies from 107 (86%) were evaluated
histological. Overall, 77 (72%) were adequate for histological
diagnosis. Inadequate biopsies corresponded to endometrial
specimens demonstrating sloughing, frank pus, and lack
of tissue. In general, more severe disease as demonstrated
by higher clinical severity score (CSS) (15.5 versus 13,
P<. 03) and severity of salpingitis based on laparoscopic
ﬁndings (P-trend < .04) was associated with unevaluable
endometrial biopsy results (Table 2). Similarly, history of
depomedroxyprogesterone acetate (DMPA) was associatedInfectious Diseases in Obstetrics and Gynecology 3
Table 1: Comparison of demographic, clinical history and signs, and laboratory ﬁndings for women laparoscopically diagnosed with
salpingitis and women undergoing tubal ligation (controls).
Variables Salpingitis HIV −/ve Controls P value
N = 125 N = 19
Demographics and clinical history
Age mean years (SD) 27.8 (5.5) 34.3 (4.1) 0.001
Education mean years (SD) 8.7 (2.9) 8.2 (2.5) 0.5
Marital status:
Single 31 (25%) 0 Ref.
Married 70 (56%) 17 (90%) 0.008
Divorced/separated 20 (16%) 2 (10%) 0.12
Ever use of contraceptives:
Oral contraceptives 55 (44%) 16 (84%) 0.001
DMPA 40 (32%) 15 (80%) 0.001
IUD 19 (15%) 8 (42%) 0.005
Condoms 48 (39%) 3 (16%) 0.04
Clinical ﬁndings
Clinical severity score (CSS), median, (mode), range 14 (8) 32 0 (0) 5 0.00
Laboratory ﬁndings
HIV-1 48 (38%) 0 0.001
Gonorrhea and/or chlamydia 23 (18.4) 0 0.04
Trichomonas vaginalis 23 (19%) 4 (21%) 0.8
Adequate endometrial biopsy 77 (72%) 12 (63%) 0.4
with an increased likelihood of obtaining an unevaluable
biopsy (P = .02). HIV-infected women were more likely
to have an unevaluable endometrial biopsy (57% versus
36%, P<. 05) than HIV-uninfected women. Although
not signiﬁcant, participants with an inadequate endometrial
histological specimen had a higher prevalence of gonorrhea
compared to those with an adequate biopsy (23% versus
12% P<0.23) (Table 2).
In multivariate analysis, after controlling for factors
found signiﬁcant in univariate analysis, the use of DMPA
at any time (adjusted OR = 3.1, 95% CI 1.1–8.5), HIV-1
infectionforwomenwithmild(AOR=4.6,95%CI1.1–18.3)
but not moderate salpingitis (AOR = 0.89, CI 0.15–5.3), or
severe salpingitis (AOR = 2.63, CI 0.68–10.2) was associated
with an increased odds of an unevaluable endometrial
biopsy. In addition, 12 (63%) of 19 specimens from HIV-1-
seronegative subjects were evaluable for histopathology.
3.3. Distribution of PMN and PC in the Endometrial Biopsy:
Eﬀect of HIV-1 Serostatus and Disease Severity. We reviewed
the distribution of PMN and PC by HIV-1 serostatus and
severity of salpingitis. Women with severe salpingitis regard-
less of HIV-1 serostatus had the highest frequency of PMN
and PC per high-power ﬁeld. Only two patients with HIV-
1 infection and salpingitis did not have PMN found in the
endometrium. Although PMN density did not increase with
severity of salpingitis among women with HIV-1 infection
(P-trend = .49), this association was signiﬁcant for HIV-1-
uninfected women with salpingitis (P-trend = .05). In con-
trast, the frequency of PCs increased with severity of salpin-
gitis among those with HIV-1 infection (P-trend = .04), but
not among HIV-1 uninfected (P-trend = .14). Furthermore,
HIV-1 infection was associated with a higher frequency of
PCs/hpf (P-trend <. 001), and presence of lymphoid follicles
(P<. 04). Only 2 (6%) of 34 HIV-1-infected women
with salpingitis did not have any plasma cells present in
the endometrium versus 23 (41%) of 56 HIV-1-uninfected
women with salpingitis.
3.4. Comparison of Endometrial Histopathology Findings and
Salpingitis. We next set out to determine the sensitivity,
speciﬁcity, and positive predictive value of four histopatho-
logic criteria for diagnosis of endometritis in comparison
to the laparoscopic diagnosis of salpingitis. The four rules
evaluated included: (a) ≥3P M Na n d≥1 PC per high-
power ﬁeld, (b) ≥1P M Na n d≥1 PC per high-power ﬁeld,
(c) ≥1 PMN per high-power ﬁeld, and (d) ≥1P Cp e r
high-power ﬁeld. Women with moderate and severe disease
were grouped together and compared to women with mild
salpingitis and to the two control groups. Table 3 outlines
the comparison between the laparoscopic diagnosis for mild
and moderate/severe salpingitis and the four histological
rules stratiﬁed by HIV-1 serostatus. Because the diagnosis
of the moderate and severe disease requires more objective
evidence of tubal inﬂammation (e.g., pus from tubes, pyos-
alpinx, abscess, and fresh adhesions) than mild disease, we
chose to gauge the sensitivity of each histological rule using
laparoscopic evidence of moderate/severe salpingitis as the
“gold standard.” Rule “a”, although less sensitive than rules
“b” through ”d” for women with moderate/severe salpingitis
(HIV-seropositive = 74% versus 63%; HIV-seronegative;
93% versus 75%), was the most speciﬁc, demonstrating4 Infectious Diseases in Obstetrics and Gynecology
Table 2: Comparison of demographic, clinical history and signs, and laboratory ﬁndings for women laparoscopically diagnosed with
salpingitis, with and without an endometrial biopsy adequate for histological evaluation.
Variables Adequate biopsy Inadequate biopsy P value
N = 77 (72%) N = 30 (28%)
Demographics and history
Age mean (SD) 27.8 (5.5) 27.9 (6.1) 0.9
Infertility ≥ 1 year 26 (39%) 3 (13%) 0.02
Ever use of contraceptive:
None 56 (51%) 23 (77%) Ref
Oral contraceptives 36 (47%) 13 (43%) 0.75
DMPA 18 (23%) 14 (47%) 0.02
Intrauterine device 13 (17%) 3 (10%) 0.37
Symptoms
Abnormal menstruation 16 (21%) 6 (21%) 1.0
Clinical examination ﬁndings
Clinical severity score, median (mode) range
Total clinical severity score 13 (8) 28 15.5 (4) 30 0.03
Laparoscopic salpingitis severity
Mild 32 (42%) 15 (50%)
Moderate 26 (36%) 3 (10%)
Severe 19 (25%) 12 (40%) 0.04
Pelvic Abscess 13 (17%) 9 (30%) 0.15
Laboratory Findings
HIV-1 27 (36%) 17 (57%) 0.05
CD4 count < 200/µL 8 (11%) 7 (23.3%) 0.09
White cell count 9.7 (6.04) 10.3 (5.5) 0.63
Lymphocytes (blood) % 26.9 (13.4) 19.1 (7.8) 0.001
Gonorrhea and/or chlamydia 11 (14%) 8 (27%) 0.13
Gonorrhea 9 (12%) 7 (23%) 0.23
Chlamydia 3 (4%) 1 (3%) 0.9
Trichomonas vaginalis 14 (19%) 6 (21%) 0.8
Bacterial vaginosis (Gram’s stain) 30 (45%) 16 (62%) 0.2
endometritis in 25% and 7% of HIV-1-seronegative and
HIV-1-seropositive controls, respectively, in comparison to
58%–67% and 38%–62% for rules “b” through “d”. Among
the 19 women enrolled with a clinical diagnosis of PID, but
who did not have salpingitis on laparoscopy, rule “a” had the
least false positive, while rule “d”, at least one plasma cell,
scored the highest false-positive rate.
4. Discussion
This study had three key ﬁndings: (1) ≥3P M Na n d≥1P C
per hpf as a histologic criteria for the diagnosis of moderate
to severe salpingitis, while performing better than the other
criteria, appears to have limited utility even more so for cases
of mild salpingitis; (2) endometrial specimens were often
unevaluable for histopathology, and unevaluable specimens
were more likely in subjects with severe salpingitis and HIV-
infection, and thus may aﬀect the utility of endometrial
histopathology to conﬁrm the clinical diagnosis of PID
in similar settings; (3) The PMN response increased with
disease severity for HIV-1 seronegative but not HIV-1
seropositive women with salpingitis.
Since Kiviat et al. published their paper, [8] histologic
endometritis has been used as a surrogate marker for
salpingitis, especially in the study of mild to moderate PID.
Even though the criteria for histologic endometritis had
never been validated in HIV-1-infected populations, several
studies of PID were conducted in high HIV-1 seroprevalence
settings [6, 7, 9, 12, 14]. The results of this study did not
validate the Kiviat et al. 1990, criteria for ≥5P M N sa n d≥1
PC for the diagnosis of PID. In the Kiviat et al. cohort, N.
gonorrhoeae and/or C. trachomatis was found in 49% of the
patient population; in comparison, the cohort in our study
had a high HIV-1 prevalence and a combined gonorrhea
and/or chlamydia prevalence of 18% (Table 1).
Similar to anotherreport,only72% of endometrial biop-
sies in our study were evaluable [1]. The increased frequency
of unevaluable endometrial biopsies in women with severe
salpingitis,likelyduetoincreasedendometrialsloughingand
presenceofpus,andHIV-1infectionfurtherlimitstheutilityInfectious Diseases in Obstetrics and Gynecology 5
Table 3: Presence and density of polymorphonuclear leucocytes (PMN) and plasma cells (PC) on histopathology of endometrial biopsies in
women with mild, moderate, and severe salpingitis at laparoscopy and controls in HIV-seropositive and -seronegative women.
Rules representing cell/hpf
Mild salpingitis Moderate/severe Salpingitis Controls without salpingitis
N = 32 N = 50 N = 62
HIV +/ve HIV −/ve HIV +/ve HIV −/ve HIV +/ve HIV −/ve
(N = 7) (N = 25) (N = 23) (N = 27) (N = 45) (N = 12)
≥3P M Na n d≥1 PC 4 (57%) 4 (16%) 17 (74%) 17 (63%) 3 (7%) 3 (25%)
≥1P M Na n d≥1 PC 7 (100%) 8 (32%) 19 (83%) 20 (74%) 17 (38%) 7 (58%)
≥1 PMN 7 (100%) 17 (68%) 21 (91%) 21 (78%) 32 (71%) 8 (67%)
≥1 PC 7 (100%) 9 (36%) 21 (91%) 21 (78%) 28 (62%) 8 (67%)
ofendometrialhistopathologyasadiagnostictoolforstudies
of PID in similar populations.
The low sensitivity of histologic endometritis for mild
salpingitis amongst women symptomatic for PID was unex-
pected. Studies of endometritis in populations of asymp-
tomatic women have consistently demonstrated a relatively
high prevalence of endometritis [10, 15, 16] which led
authorstodescribeendometritisasanintermediateinfection
to PID. Eckert et al. studied HIV-1-infected women pre-
senting to a family planning clinic and found endometritis
in 38% of participants [10]. This is a higher prevalence
than what we found in HIV-1-negative women (16%)
and a lower prevalence than what we found in HIV-1-
seropositive women (57%) with mild salpingitis using less
stringent criteria for endometritis. Furthermore, a prior
laparoscopic study demonstrated salpingitis in the absence
of endometritis [7]. An alternative explanation may result
from the subjectivity of the laparoscopic criteria for mild
salpingitis that leads to misclassiﬁcation of cases [13].
The distribution of PMNs and PCs in the endometrium
of women with salpingitis was aﬀected by HIV-1 serostatus
and disease severity. PMNs are only found in the healthy
endometrium during menses [17], and form part of the
endometrial immune response, they are also the ﬁrst line
immune defense against bacterial infections. The increased
density of PMN with severe disease in HIV-1-uninfected but
not in HIV-1-infected women with salpingitis is not well
understood. Consistent with other studies [7, 9, 10, 14],
we found increased PC endometritis with HIV-1 infection.
This could represent HIV-1 infection in the genital tract
[18]; chronic plasma cell endometritis [11, 14]; or the
presence of opportunistic infections. Cherpes et al. reported
an association between HSV-2 seropositivity and plasma
cell endometritis [19]; notably HSV-2 is extremely prevalent
among HIV-1-infected persons (KAIS 2007 [20]. Contrary
to these ﬁndings, Eckert et al. [10]e v a l u a t e d2 0e n d o m e t r i a l
biopsy samples from women with asymptomatic histologic
endometritis and failed to detect herpes simplex virus by
PCR, and cytomegalovirus was detected equally in women
with and without histological endometritis. Mycoplasma
genitalium is another potential cause of endometritis [21].
One limitation of this study is that HIV-1-infected
controls did not undergo laparoscopic evaluation. Therefore,
unlikely we cannot ﬁrmly exclude subclinical salpingitis
from this population as we can for the HIV-1-seronegative
controls. Furthermore, we did not attempt to detect sus-
pected etiologies of endometritis such as bacteria other than
N. gonorrhoeae and C. trachomatis including M. genitalium
[14] and potential etiologies such as cytomegalovirus and
herpes simplex virus infection. Such data might help to
elucidate the reason for the diﬀerent ﬁndings among HIV-1-
seropositive and HIV-1-seronegative women with salpingitis
in regards to endometrial histopathology.
This study raises some important questions regarding
PID and its sequelae. With increased access to highly active
antiretroviral therapy (HAART), HIV-1-infected women are
living longer. Population data from Uganda [22] plus others
[23] have demonstrated reduced fertility in HIV-1-infected
women regardless of disease stage. It is plausible that PC
endometritis may lead to reduced fertility. Further research
is required to determine if women using HAART return
to normal fertility or not. Lastly, although endometrial
histopathologyservesasareasonablesurrogateforsalpingitis
in HIV-1-uninfected populations, its utility in populations
with a high HIV-1 seroprevalence appears to be limited.
Discovery of a sensitive and speciﬁc biomarker or set of
biomarkers for salpingitis could facilitate further research on
PID and its sequelae in such settings.
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